Nyseamerican catx.
About BTTR. Better Choice Company Inc. operates as an animal health and wellness company. Its products portfolio includes naturally formulated kibble and canned dog and cat foods, freeze-dried raw dog foods and treats, vegan dog foods and treats, oral care products and supplements, as well as toppers, dental products, chews, and grooming products.
COLUMBUS, Ga. and SEATTLE, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Aflac Incorporated (NYSE: AFL), a Fortune 500 company and leading provider of supplemental health insurance in Japan and the United States, and Trupanion, Inc. (Nasdaq: TRUP), the leading provider of medical insurance for cats and dogs, jointly announce Trupanion’s renewal of an S-3 ...Nov 16, 2023 · Total Valuation. CATX has a market cap or net worth of $72.61 million. The enterprise value is $57.75 million. Market Cap. 72.61M. Enterprise Value. 57.75M. Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report) was the target of a significant increase in short interest in October.As of October 31st, there was short interest totalling ...Nov 8, 2023 · Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report)’s stock price shot up 3.8% on Tuesday .The company traded as high as 0.28 and last traded at 0.27. 292,900 shares changed ...
Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX – Get Free Report)’s share price dropped 3.4% on Friday . The company traded as low as 0.61 and last traded at 0.61. Approximately 148,900 ...
Fiscal year is July - June. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for Perspective Therapeutics, Inc. (CATX). See many years of revenue, expenses and ...
USAF’s Preliminary B-21 Flight Falls Behind Schedule, but Only Slightly. Posted by Keala Milles on Mar 22nd, 2023 . It is a few months late, but the United States Air Force’s new B-21 Raider ...Dec 1, 2023 · Perspective Therapeutics (CATX) Social Media Sentiment and Mentions. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Get daily stock ideas from top-performing Wall Street analysts. Find the latest Perspective Therapeutics, Inc. (CATX) stock quote, history, news and other vital information to help you with your stock trading and investing.As of November 15th, there was short interest totalling 1,840,000 shares, a growth of 10.8% from the October 31st total of 1,660,000 shares. Based on an average daily trading volume, of 390,100 ...
Nov 18, 2023 · Perspective Therapeutics Stock Up 0.5 %. CATX opened at 0.26 on Friday. The stock has a market capitalization of $73.00 million, a PE ratio of -2.60 and a beta of 1.70. Perspective Therapeutics ...
Dec 4, 2023 · Ashford Inc. (NYSEAMERICAN:AINC – Get Free Report) was the recipient of a large decrease in short interest in the month of November. As of November 15th, there was short interest totalling 7,900 ...
Stock Exchange NYSEAMERICAN. Ticker Symbol HUSA. Full Company Profile. Financial Performance. In 2022, HUSA's revenue was $1.64 million, an increase of 23.20% compared to the previous year's $1.33 million. Losses were -$744,279, -29.70% less than in 2021. Financial Statements. News. All; Videos;Feb 7, 2023 · The Company currently trades on the NYSE American as Isoray, Inc. under ticker symbol ISR which will change to Perspective Therapeutics, Inc. with the ticker symbol of CATX on February 21, 2023. Jul 10, 2023 · Cesium-131. Perspective Therapeutics is the only company in the world manufacturing and distributing Cesium 131 brachytherapy radioisotope seeds. Perspective Therapeutics (CATX) delivered earnings and revenue surprises of -33.33% and 20%, respectively, for the quarter ended June 2023. Do the numbers hold clues to what lies ahead for the stock?Cybin Inc. (NYSEAMERICAN:CYBN – Get Free Report) was up 2.4% during trading on Tuesday . The stock traded as high as $0.65 and last traded at $0.63. Approximately 3,755,446 shares traded hands during mid-day trading, an increase of 46% from the average daily volume of 2,566,639 shares. The stock had previously closed at …Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment applications for cancers.
Perspective Therapeutics (CATX) Social Media Sentiment and Mentions. View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. …Jonestrading started coverage on shares of Perspective Therapeutics (NYSEAMERICAN:CATX – Free Report) in a research note published on Wednesday morning, Benzinga reports. The brokerage issued a buy rating and a $1.40 target price on the stock. Perspective Therapeutics Stock Performance Perspective Therapeutics stock opened at 0.26 on Wednesday. Perspective Therapeutics has a 1 year low […]Find the latest Perspective Therapeutics, Inc. (CATX) stock quote, history, news and other vital information to help you with your stock trading and investing.Nov 30, 2023 · About NYSEAMERICAN:CATX Perspective Therapeutics Stock Price, News & Analysis (NYSEAMERICAN:CATX) 0.26 0.00 (-1.24%) (As of 11/22/2023 06:30 PM ET) Compare Today's Range 0.25 0.26 50-Day Range N/A 52-Week Range 0.21 0.73 Volume 121,100 shs Average Volume 603,052 shs Market Capitalization $71.55 million P/E Ratio N/A Dividend Yield N/A Get the latest NYSE American Composite Index (XAX) value, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
SEATTLE, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), today announced that two upcoming investigator-initiated trials (IIT) were presented at the North American Neuroendocrine Tumor Society (NANETS) 2023 Symposium in Montreal, Canada, which was held October 4-6 ... AlphaTime Acquisition Corp (NASDAQ:ATMCW – Get Free Report) was the target of a large increase in short interest in June. As of June 30th, there was short interest totalling 1,200 shares, an ...
Stock analysts at Jonestrading started coverage on shares of Perspective Therapeutics (NYSEAMERICAN:CATX – Get Free Report) in a research report issued on Wednesday, Benzinga reports. The brokerage set a “buy” rating and a $1.40 price target on the stock. Perspective Therapeutics Stock Up 2.8 % NYSEAMERICAN:CATX opened at …Stock Exchange NYSEAMERICAN. Ticker Symbol ATNM. Full Company Profile. Financial Performance. In 2022, ATNM's revenue was $1.03 million, a decrease of -9.97% compared to the previous year's $1.14 million. Losses were -$33.02 million, 33.3% more than in 2021. Financial Statements.Stock Exchange NYSEAMERICAN. Ticker Symbol LNG. Full Company Profile. Financial Performance. Financial Statements. Analyst Forecast. According to 12 analysts, the average rating for LNG stock is "Strong Buy." The 12-month stock price forecast is $196.67, which is an increase of 9.00% from the latest price.On Wednesday, October 11th, Carl Ledbetter sold 10,016 shares of Cloudflare stock. The shares were sold at an average price of $66.54, for a total value of $666,464.64.Perspective Therapeutics, Inc. (NYSEAMERICAN:CATX) posted its quarterly earnings results on Tuesday, November, 14th. The company reported ($0.04) …Perspective Therapeutics Inc. options quotes data for sells and puts, including CATX last price, change and volume.CATX. Real Time Quote. About Perspective Therapeutics Inc. Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment ...Get the latest NYSE American Composite Index (XAX) value, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
SEATTLE, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (NYSE AMERICAN: CATX), today announced third quarter financial results for the period ended …
Perspective Therapeutics (NYSEAMERICAN:CATX) has a recorded net income of -$7.27 million. CATX has generated -0.09 earnings per share over the last four …
Stock Exchange NYSEAMERICAN. Ticker Symbol ZOM. Full Company Profile. Financial Performance. In 2022, Zomedica's revenue was $18.93 million, an increase of 358.02% compared to the previous year's $4.13 million. Losses were -$17.86 million, -2.84% less than in 2021. Financial Statements.USAF’s Preliminary B-21 Flight Falls Behind Schedule, but Only Slightly. Posted by Keala Milles on Mar 22nd, 2023 . It is a few months late, but the United States Air Force’s new B-21 Raider ...Oct 16, 2023 · Company profile for Perspective Therapeutics, Inc. (CATX) with a description, list of executives, contact details and other key facts. ... NYSEAMERICAN: CATX · IEX ... CATX. Real Time Quote. About Perspective Therapeutics Inc. Perspective Therapeutics, Inc. is a medical technology and radiopharmaceutical company, which engages in the provision of treatment ...Find the latest iBio, Inc. (IBIO) stock quote, history, news and other vital information to help you with your stock trading and investing.Interactive Chart for Perspective Therapeutics, Inc. (CATX), analyze all the data with a huge range of indicators. USAF’s Preliminary B-21 Flight Falls Behind Schedule, but Only Slightly. Posted by Keala Milles on Mar 22nd, 2023 . It is a few months late, but the United States Air Force’s new B-21 Raider ...COLUMBUS, Ga. and SEATTLE, Dec. 04, 2023 (GLOBE NEWSWIRE) -- Aflac Incorporated (NYSE: AFL), a Fortune 500 company and leading provider of …Fiscal year is July - June. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed annual and quarterly income statement for Perspective Therapeutics, Inc. (CATX). See many years of revenue, expenses and ...173.54%. Free cash flow. Amount of cash a business has after it has met its financial obligations such as debt and outstanding payments. -30.77M. -72.58%. Get the latest I-80 Gold Corp (IAUX) real ...Fiscal year is July - June. Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual ( 10-K) and quarterly ( 10-Q) reports submitted to the Securities and Exchange Commission (SEC). Detailed cash flow statements for Perspective Therapeutics, Inc. (CATX), including operating cash flow, capex and free …
Interactive Chart for Perspective Therapeutics, Inc. (CATX), analyze all the data with a huge range of indicators. Perspective Therapeutics Inc. Institutional investors purchased a net $3.7 million shares of CATX during the quarter ended March 2019 and now own 13.04% of the total shares outstanding. This is a ...SEATTLE, Oct. 10, 2023 (GLOBE NEWSWIRE) -- Perspective Therapeutics, Inc. (“Perspective” or “the Company”) (NYSE AMERICAN: CATX), today announced that two upcoming investigator-initiated trials (IIT) were presented at the North American Neuroendocrine Tumor Society (NANETS) 2023 Symposium in Montreal, Canada, which was held October 4-6 ...NYSE American offers: Dedicated e-DMMs with quoting obligations in NYSE American-listed securities to enhance price discovery and liquidity. Trading in all 8,000+ NMS securities in a fully electronic manner, including electronic auctions in NYSE American-listed securities. Discretionary pegged orders, which peg to the near side of the protected ... Instagram:https://instagram. best dental plans massachusettsstock asianbest trading vpstmf stock dividend Nov 16, 2023 · Total Valuation. CATX has a market cap or net worth of $72.61 million. The enterprise value is $57.75 million. Market Cap. 72.61M. Enterprise Value. 57.75M. Read Tanger Factory Outlet Centers, Inc. (NYSE:SKT) Receives Consensus Rating of “Hold” from Brokerages at Defense World shm etfcancer insurance providers CATX Perspective Therapeutics Inc stock NYSEAMERICAN. Market Open. 5/23/2023 12:07:30 PM EDT. 0.5115 USD +0.294 % (+0.0015) 33,249. 0.4692 Bid 0.5458 Ask 0.0766 ...(NYSE AMERICAN: CATX), today announced the completion of cohort 1 dosing in the Phase 1/2a clinical trial of [212Pb]VMT-α-NET in patients with unresectable or ... top 5g stocks USAF’s Preliminary B-21 Flight Falls Behind Schedule, but Only Slightly. Posted by Keala Milles on Mar 22nd, 2023 . It is a few months late, but the United States Air Force’s new B-21 Raider ...View the latest Perspective Therapeutics Inc. (CATX) stock price, news, historical charts, analyst ratings and financial information from WSJ.